Study #2022-0943
Induced pluripotent stem cell derived genetically modified macrophages (iMacs) for personalized cell-based cancer therapy
MD Anderson Study Status
Enrolling
Treatment Agent
Description
iMacs for personalized cell-based cancer therapy
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Brain and Nervous System
Study phase:
Not applicable
Physician name:
Chibawanye Ene
Department:
Neurosurgery
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.